Revvity's stock has returned 14.9% over the past six months, outperforming the S&P 500 by 5.6% and reaching $112.79 per share, but analysts highlight three reasons to avoid the stock. Organic revenue growth averaged just 2.9% annually over the last two years, lagging the sector and signaling weak core demand. Adjusted operating margin shrank by 6 percentage points over five years to 27%, while earnings per share fell 14.7% annually over the same period, outpacing revenue declines due to a rigid cost base. With shares trading at 20.3 times forward earnings, the firm suggests better opportunities exist elsewhere, including a dominant aerospace company.
Revvity Inc.Adjusted operating margin shrank by 6 percentage points over five years to 27%, while earnings per share fell 14.7% annually over the same period
NVIDIA Corporation